Background illustration for clinical trials search

Paid Clinical Trials Glendale

Discover 3,553 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of ARC-02 in B-cell NHL

for
B-cell Non Hodgkin Lymphoma
Location: Los Angeles CA, Spokane WA
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07691606

Phase1, Recruiting
Active & Responsive

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

for
Bipolar Disorder Type I With Mania
Location: Culver City CA, Bellflower CA, La Habra CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT06929273

Phase3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

for
Mania, Bipolar Disorder
Location: Culver City CA, Bellflower CA, La Habra CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT07140913

Phase3, Recruiting
Active & Responsive

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

for
Lung Cancer Diagnosis
Location: Los Angeles CA, Houston TX, Reno NV, Portland OR,
Sponsor: Freenome Holdings Inc.

Sex: All

Age: 50+

Code: NCT06122077

Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Los Angeles CA, Cerritos CA, Bakersfield CA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Los Angeles CA, San Francisco CA, Aurora CO,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 12+

Code: NCT05533697

Phase1, Phase2, Recruiting
Active & Responsive

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

for
Melanoma, Unresectable Melanoma
Location: Los Angeles CA, New York NY, Boston MA
Sponsor: NYU Langone Health

Sex: All

Age: 18 - 70+

Code: NCT05428007

Phase2, Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Encino CA, Santa Ana CA, Mountain View CA, Gilbert AZ,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07496567

Phase2, Phase3, Recruiting
Active & Responsive

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

for
EDS, Cataplexy, Fatigue, Narcolepsy
Location: Los Angeles CA, Redwood City CA, San Ramon CA,
Sponsor: Harmony Biosciences Management, Inc.

Sex: All

Age: 18+

Code: NCT07675135

Phase3, Recruiting
Active & Responsive

Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.

for
Phantom Limb Syndrome With Pain
Location: Santa Monica CA, Sacramento CA, San Anselmo CA,
Sponsor: The Ketamine Research Foundation

Sex: All

Age: 18 - 65

Code: NCT07276542

Phase2, Phase3, Recruiting
Active & Responsive

Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors

for
Solid Tumor Cancer
Location: Santa Monica CA
Sponsor: Sarcoma Oncology Research Center, LLC

Sex: All

Age: 18+

Code: NCT07671534

Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

for
Degenerative Disc Disease
Location: Santa Monica CA, Thousand Oaks CA, Phoenix AZ,
Sponsor: DiscGenics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07254806

Phase3, Recruiting
Active & Responsive

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

for
Knee Cartilage Defects
Location: Santa Monica CA, Encinitas CA, La Jolla CA, La Mesa CA,
Sponsor: Medipost, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07339111

Phase3, Recruiting
Active & Responsive

A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)

for
Lumbar Disc Disease
Location: Santa Monica CA, Walnut Creek CA, Greenwood Village CO,
Sponsor: BioRestorative Therapies

Sex: All

Age: 18+

Code: NCT04042844

Phase2, Recruiting
Active & Responsive

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-Resistant Prostate Cancer
Location: Los Angeles CA, Whittier CA, San Francisco CA,
Sponsor: Zenith Epigenetics

Sex: Male

Age: 18+

Code: NCT04986423

Phase2, Recruiting
Active & Responsive

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

for
Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms,
Location: Los Angeles CA, Fullerton CA, Houston TX, Urbana IL,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05386108

Phase1, Phase2, Recruiting
Active & Responsive

Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

for
Solid Tumor
Location: Santa Monica CA, El Segundo CA, Stanford CA,
Sponsor: Alyssum Therapeutics

Sex: All

Age: 18+

Code: NCT06234098

Phase1, Phase2, Recruiting
Active & Responsive

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

for
Breast Neoplasms, Breast Cancer
Location: Santa Monica CA, Tigard OR, Billings MT, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06797635

Phase2, Recruiting
Active & Responsive

Pembrolizumab and Pemetrexed for Progressive Chordoma

for
Chordomas, Chordoma
Location: Santa Monica CA
Sponsor: Saint John's Cancer Institute

Sex: All

Age: 18+

Code: NCT06794645

Phase2, Recruiting
Active & Responsive

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

for
Esophageal Squamous Cell Carcinoma
Location: Los Angeles CA, Tucson AZ, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05319730

Phase1, Phase2, Recruiting